Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
3-(4-Chlorophenyl)-4,5-dihydro-N'-(1-iminoethyl)-4-phenyl-N-[[4-(trifluoromethyl)phenyl]sulfonyl]-1H-pyrazole-1-carboximidamide, can be used in synthesis of novel dual-target compounds with antagonist/inverse agonist activity at cannabinoid receptor type 1 (CB1R) and inhibitory effect on inducible nitric oxide synthase (iNOS).
?您的位置：![3-(4-Chlorophenyl)-4,5-dihydro-N'-(1-iminoethyl)-4-phenyl-N-[[4-(trifluoromethyl)phenyl]su](/images/defaultpic.gif "3-(4-Chlorophenyl)-4,5-dihydro-N'-(1-iminoethyl)-4-phenyl-N-[[4-(trifluoromethyl)phenyl]su")
